2984 related articles for article (PubMed ID: 7651733)
21. Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.
Schreiber E; Merchant RE; Wiestler OD; Fontana A
Neurosurgery; 1994 Jan; 34(1):129-35. PubMed ID: 8121549
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal organization of mammalian POU domain factors.
Xia YR; Andersen B; Mehrabian M; Diep AT; Warden CH; Mohandas T; McEvilly RJ; Rosenfeld MG; Lusis AJ
Genomics; 1993 Oct; 18(1):126-30. PubMed ID: 8276396
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
24. The POU gene Brn-5 is induced by neuregulin and is restricted to myelinating Schwann cells.
Wu R; Jurek M; Sundarababu S; Weinstein DE
Mol Cell Neurosci; 2001 Apr; 17(4):683-95. PubMed ID: 11312604
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
Wang Y; Becker D
Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
[TBL] [Abstract][Full Text] [Related]
26. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
27. POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification.
Gan L; Wang SW; Huang Z; Klein WH
Dev Biol; 1999 Jun; 210(2):469-80. PubMed ID: 10357904
[TBL] [Abstract][Full Text] [Related]
28. Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors.
Smit DJ; Smith AG; Parsons PG; Muscat GE; Sturm RA
Eur J Biochem; 2000 Nov; 267(21):6413-22. PubMed ID: 11029584
[TBL] [Abstract][Full Text] [Related]
29. A role for the POU-III transcription factor Brn-4 in the regulation of striatal neuron precursor differentiation.
Shimazaki T; Arsenijevic Y; Ryan AK; Rosenfeld MG; Weiss S
EMBO J; 1999 Jan; 18(2):444-56. PubMed ID: 9889200
[TBL] [Abstract][Full Text] [Related]
30. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
Cook AL; Sturm RA
Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
[TBL] [Abstract][Full Text] [Related]
31. The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells.
Dennis JH; Budhram-Mahadeo V; Latchman DS
Oncogene; 2001 Aug; 20(36):4961-71. PubMed ID: 11526481
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene.
Kobi D; Steunou AL; Dembélé D; Legras S; Larue L; Nieto L; Davidson I
Pigment Cell Melanoma Res; 2010 Jun; 23(3):404-18. PubMed ID: 20337985
[TBL] [Abstract][Full Text] [Related]
33. Expression studies of pigmentation and POU-domain genes in human melanoma cells.
Sturm RA; O'Sullivan BJ; Thomson JA; Jamshidi N; Pedley J; Parsons PG
Pigment Cell Res; 1994 Aug; 7(4):235-40. PubMed ID: 7855069
[TBL] [Abstract][Full Text] [Related]
34. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
[TBL] [Abstract][Full Text] [Related]
35. Isolation of the human genomic brain-2/N-Oct 3 gene (POUF3) and assignment to chromosome 6q16.
Atanasoski S; Toldo SS; Malipiero U; Schreiber E; Fries R; Fontana A
Genomics; 1995 Mar; 26(2):272-80. PubMed ID: 7601453
[TBL] [Abstract][Full Text] [Related]
36. Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extraction.
Smith AG; Brightwell G; Smit SE; Parsons PG; Sturm RA
Melanoma Res; 1998 Feb; 8(1):2-10. PubMed ID: 9508370
[TBL] [Abstract][Full Text] [Related]
37. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.
Albino AP; Sozzi G; Nanus DM; Jhanwar SC; Houghton AN
Oncogene; 1992 Nov; 7(11):2315-21. PubMed ID: 1437153
[TBL] [Abstract][Full Text] [Related]
38. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
[TBL] [Abstract][Full Text] [Related]
39. The Brn-2 transcription factor links activated BRAF to melanoma proliferation.
Goodall J; Wellbrock C; Dexter TJ; Roberts K; Marais R; Goding CR
Mol Cell Biol; 2004 Apr; 24(7):2923-31. PubMed ID: 15024080
[TBL] [Abstract][Full Text] [Related]
40. POU domain genes are differentially expressed in the early stages after lineage commitment of the PNS-derived stem cell line, RT4-AC.
Donahue LM; Reinhart AJ
Brain Res Dev Brain Res; 1998 Mar; 106(1-2):1-12. PubMed ID: 9554933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
